Skip to content

Tidepool Loop receives FDA clearance

Tidepool Loop is the first fully interoperable automated insulin dosing app, cleared by the FDA, that originated as a patient-led initiative

To the left, a phone displays the Tidepool Loop. To the right, an Apple Watch also displays Tidepool Loop.

Tidepool Loop™ is commercially available as a licensed and third-party distributed product, most recently by Sequel Med Tech as twiist Loop.

2 Apple Watches displaying Tidepool Loop.

Tidepool Loop™ is commercially available as a licensed and third-party distributed product, most recently by Sequel Med Tech as twiist Loop.

Discretion on your wrist. It’s about time.

First automated insulin dosing app with Apple Watch compatibility

Born from the #WeAreNotWaiting community of innovators, Tidepool Loop is the first automated insulin dosing app cleared to enable control from a compatible Apple Watch.

Tidepool Loop is more than an app.

With Tidepool Loop, we are reimagining how people with diabetes can get started with automated insulin dosing, how to ask for help when needed, and how to fit control, discretion, and flexibility into your diabetes management.

Tidepool Loop is an app designed to automate your insulin dosing, intended for the management of type 1 diabetes in people with diabetes six years of age or older.

Announcements

Want to be the first to hear about our upcoming user research opportunities? Sign up to stay in the loop.

Tidepool & Sequel partnership

New AID system to include Tidepool Loop technology

“The twiist™ AID system powered by Tidepool takes advantage of the Tidepool Loop algorithm, the first and only FDA-cleared glycemic controller that originated as a patient-led initiative. We are thrilled to see twiist come to market and bring new advancements to people living with type 1 diabetes.” says Howard Look, Founder and Chief Executive Officer of Tidepool.

Tidepool Loop & Android

Beginning the work to expand the reach of Tidepool Loop

Tidepool was founded with a mission to help all people with insulin-requiring diabetes safely achieve great outcomes. Through an extremely generous anonymous donation, we are now able to start the work to expand market access to Tidepool Loop and we can’t wait to allow broader access to one of the most sophisticated diabetes management tools.

Want to be in the loop?

Please fill out the Tidepool Loop interest form if you’d like to get updates on Tidepool Loop as there’s news to share.